|
May 23
|
GSK (LSE:GSK) Secures FDA Approval For COPD Treatment, Eyes European Nod For Blenrep
|
|
May 23
|
GSK plc (GSK)’s Asthma Drug Gets FDA Nod to Treat ‘Smoker’s Lung’
|
|
May 22
|
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
|
|
May 21
|
ATS 2025: GSK strengthens argument for twice-annual depemokimab
|
|
May 19
|
Why These 4 Women-Run Companies Deserve a Spot in Your Portfolio?
|
|
May 19
|
GSK’s Blood-Cancer Treatment Combinations Approved in Japan
|
|
May 15
|
New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel
|
|
May 14
|
GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion
|
|
May 14
|
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q4 2025 Earnings Call Highlights: Strong ...
|
|
May 13
|
Is GSK plc (GSK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
|
|
May 13
|
iTeos Stock Soars Despite Trial Setback On Liquidation Buzz And Solid Cash Pile
|
|
May 12
|
Glaxo (GSK) Upgraded to Buy: Here's What You Should Know
|
|
May 12
|
Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks
|
|
May 12
|
Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices
|
|
May 10
|
Don't Race Out To Buy GSK plc (LON:GSK) Just Because It's Going Ex-Dividend
|
|
Feb 17
|
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ...
|
|
Feb 15
|
GSK shares shorted by leading U.S. hedge fund, The Times reports
|
|
Feb 15
|
Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend
|
|
Feb 14
|
Hedge fund Citadel takes short position in GSK, FT reports
|
|
Feb 13
|
ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
|